pinobanksin has been researched along with galangin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuda, H; Nakamura, S; Nakashima, S; Oda, Y; Yoshikawa, M | 1 |
| Akagi, K; Irie, K; Katayama, S; Masuda, Y; Murakami, K; Nakagawa, Y; Sato, M; Takegoshi, K; Uno, M | 1 |
| Ebringer, L; Krizková, L; Nagy, M; Polónyi, J | 1 |
3 other study(ies) available for pinobanksin and galangin
| Article | Year |
|---|---|
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
Topics: Alpinia; Animals; Antineoplastic Agents; Enzyme Inhibitors; Flavonoids; Kaempferols; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Oxidoreductases; Rhizome | 2009 |
Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Catechols; Humans; Lysine; Norleucine; Peptide Fragments; Quercetin | 2013 |
The effect of flavonoids on ofloxacin-induced mutagenicity in Euglena gracilis.
Topics: Animals; Antimutagenic Agents; Chloroplasts; Euglena gracilis; Flavanones; Flavonoids; Mutagens; Ofloxacin | 1998 |